Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04702477
Other study ID # Pro00076863
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2018
Est. completion date January 31, 2020

Study information

Verified date December 2020
Source Clemson University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Examining a number of health outcomes in those with diabetes and prediabetes before and after a group-based mindfulness intervention.


Description:

This is a pilot study to examine the feasibility of integrating a mindfulness-based stress reduction (MBSR) intervention in addition to an existing group-based, peer supported clinical care model (JUMP) among patients with pre-diabetes or diabetes using a mixed-method design.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date January 31, 2020
Est. primary completion date January 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years or older - English speaking - Having a diagnosis of diabetes or prediabetes - Participation in a previous group-based clinical care model-JUMP (as in "JUMPing into Diabetes Control") Exclusion Criteria: - Under 18 years old - Non-English Speaking - not having a diagnosis of diabetes or prediabetes - No participation in JUMP model

Study Design


Intervention

Behavioral:
Mindfulness Based Stress Reduction
Mindfulness Based Stress Reduction (MBSR) is a well-documented approach to reduce participants' stress level [19], with the existing group-based peer support, self-empowerment, and lifestyle counseling intervention. MBSR is a type of meditation therapy with the goal of actively cultivating conscious attention and awareness to enhance health benefits. This included 10 hours of intervention with groups of 3-5 people.

Locations

Country Name City State
United States Prisma Health Greenville South Carolina

Sponsors (3)

Lead Sponsor Collaborator
Clemson University Prisma Health-Upstate, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intervention Attendance How many hours of intervention sessions an individual attended 8-weeks while completing the intervention
Secondary Perceived Stress Scale Change in perceived stress measured by 4 Items to assess perceived stress where higher levels indicating higher levels of stress with a range of 4 to 20. Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Depression Change in depression scores from the Center for Epidemiologic Studies Depression Scale (CES-D), where higher scores indicate higher levels of depression with a range of 0 to 80. Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Anxiety Change in anxiety assessed using the Generalized anxiety disorder 7-item scale (GAD-7). Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Medication Adherence Change in medication adherence assessed using the 8-item Morisky Medication Adherence Scale. A higher score indicates higher adherence with a range of 0 to 8. Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Perceived Health Status Change in perceived health status assessed using a question asking participants to rate their health status on a 5-points rating scale where lower ratings indicate higher levels of perceived health status and higher ratings indicate lower levels of perceived health status. Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Sleep Quality Change in sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI) ranges from 7 to 28, with higher scores indicating worse sleep quality. Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Physical Activity Change in physical activity assessed using the Rapid Assessment of Physical Activity Scale (RAPA). Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Mindfulness Change in Mindfulness assessed using a 15-item Five-Facet Mindfulness Questionnaire (FFMQ). Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary HbA1C levels HbA1C blood levels Up to 3 months before intervention, immediately following intervention, one month after intervention
Secondary Program satisfaction and barriers for attending sessions Open ended questions to address engagement in the intervention, perceived usefulness of the MBSR, recommendations for intervention modification, what participants enjoyed most/least about the intervention, and reasons for missing intervention sessions. This is a qualitative measure, not numeric values were assigned. Based on Zgierska A, Rabago D, Zuelsdorff M, Coe C, Miller M, Fleming M. Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. J Addict Med. 2008 Sep;2(3):165-73. doi: 10.1097/ADM.0b013e31816f8546. Immediately following intervention
See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4